Overweight and obesity are associated with neuronal injury in the human cerebellum and hippocampus in young adults: A combined MRI, serum marker and gene expression study

Translational Psychiatry

Volumn 2, Issue , 2012, Pages

  Mueller, K ^a   Sacher, J ^a,b   Arelin, K ^a,b   Holiga, S ^a   Kratzsch, J ^b   Villringer, A ^a,b   Schroeter, M L ^a,b,c  

^a MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c German Consortium for Frontotemporal Lobar Degeneration   (Germany)

Author keywords

hippocampus; magnetic resonance imaging; neuron specific enolase; neuronal injury; obesity

Indexed keywords

BIOLOGICAL MARKER; NEURON SPECIFIC ENOLASE; ENOLASE;

ADULT; ARTICLE; BRAIN REGION; CEREBELLUM; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DENSITY; EXECUTIVE FUNCTION; FEMALE; GENE EXPRESSION; GRAY MATTER; HIPPOCAMPUS; HUMAN; LINGUISTICS; MALE; MEMORY; NERVE CELL LESION; NERVE CELL PLASTICITY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; VOLUMETRY; BLOOD; ENZYMOLOGY; GENETICS; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; BIOLOGICAL MARKERS; CEREBELLUM; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEURONAL PLASTICITY; OBESITY; OVERWEIGHT; PHOSPHOPYRUVATE HYDRATASE;

EID: 84870843622     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2012.121     Document Type: Article

References (31)

1. Kenny PJ. Common cellular and molecular mechanisms in obesity and drug addiction. Nat Rev Neurosci 2011; 12: 638-651.
2. Ziauddeen H, Farooqi IS, Fletcher PC. Obesity and the brain: how convincing is the addiction model? Nat Rev Neurosci 2012; 13: 279-286.
3. Elias MF, Elias PK, Sullivan LM, Wolf PA, D'Agostino RB. Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord 2003; 27: 260-268. (Pubitemid 36255810)
4. McCrimmon RJ, Ryan CM, Frier BM. Diabetes and cognitive dysfunction. Lancet 2012; 379: 2291-2299.
5. Sellbom KS, Gunstad J. Cognitive function and decline in obesity. J Alzheimers Dis 2012; 30: S89-S95.
6. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med 2003; 163: 1524-1528. (Pubitemid 36835095)
7. Gustafson D, Lissner L, Bengtsson C, Bjorkelund C, Skoog IA. 24-year follow-up of body mass index and cerebral atrophy. Neurology 2004; 63: 1876-1881. (Pubitemid 39532384)
8. Horstmann A, Busse FP, Mathar D, Muller K, Lepsien J, Schlogl H et al. Obesity-Related Differences between Women and Men in Brain Structure and Goal-Directed Behavior. Front Hum Neurosci 2011; 5: 58.
9. Mueller K, Anwander A, Moller HE, Horstmann A, Lepsien J, Busse F et al. Sex-dependent influences of obesity on cerebral white matter investigated by diffusion-tensor imaging. PLoS One 2011; 6: e18544.
10. Pannacciulli N, Del Parigi A, Chen K, Le DS, Reiman EM, Tataranni PA. Brain abnormalities in human obesity: a voxel-based morphometric study. Neuroimage 2006; 31: 1419-1425. (Pubitemid 43949229)
11. Guzel A, Er U, Tatli M, Aluclu U, Ozkan U, Duzenli Y et al. Serum neuron-specific enolase as a predictor of short-term outcome and its correlation with Glasgow Coma Scale in traumatic brain injury. Neurosurg Rev 2008; 31: 439-445.
12. Chaves ML, Camozzato AL, Ferreira ED, Piazenski I, Kochhann R, Dall'Igna O et al. Serum levels of S100B and NSE proteins in Alzheimer's disease patients. J Neuroinflammation 2010; 7: 6.
13. Mugler JP 3rd, Brookeman JR. Three-dimensional magnetization-prepared rapid gradientecho imaging (3D MP RAGE). Magn Reson Med 1990; 15: 152-157. (Pubitemid 20284023)
14. Schroeter ML, Abdul-Khaliq H, Krebs M, Diefenbacher A, Blasig IE. Serum markers support disease-specific glial pathology in major depression. J Affect Disord 2008; 111: 271-280.
15. Schroeter ML, Abdul-Khaliq H, Krebs M, Diefenbacher A, Blasig IE. Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia-original research and meta-analysis. Psychiatry Res 2009; 167: 66-72.
16. Streitbürger DJ, Arelin K, Kratzsch J, Thiery J, Steiner J, Villringer A et al. Validating serum S100B and neuron-specific enolase as biomarkers for the human brain-A combined serum, gene expression and MRI study. PLoS One 2012; 7: e43284.
17. Masuo K, Straznicky NE, Lambert GW, Katsuya T, Sugimoto K, Rakugi H et al. Leptinreceptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic nerve activation in a Caucasian male population. Hypertens Res 2008; 31: 1093-1100.
18. Burghuber OC, Worofka B, Schernthaner G, Vetter N, Neumann M, Dudczak R et al. Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer. Cancer 1990; 65: 1386-1390. (Pubitemid 20097167)
19. Herculano-Houzel S. Not all brains are made the same: new views on brain scaling in evolution. Brain Behav Evol 2011; 78: 22-36.
20. Grillo CA, Piroli GG, Junor L, Wilson SP, Mott DD, Wilson MA et al. Obesity/hyperleptinemic phenotype impairs structural and functional plasticity in the rat hippocampus. Physiol Behav 2011; 105: 138-144.
21. Jagust W, Harvey D, Mungas D, Haan M. Central obesity and the aging brain. Arch Neurol 2005; 62: 1545-1548. (Pubitemid 41434559)
22. Convit A, de Leon MJ, Tarshish C, De Santi S, Kluger A, Rusinek H et al. Hippocampal volume losses in minimally impaired elderly. Lancet 1995; 345: 266.
23. de Toledo-Morrell L, Goncharova I, Dickerson B, Wilson RS, Bennett DA. From healthy aging to early Alzheimer's disease: in vivo detection of entorhinal cortex atrophy. Ann N Y Acad Sci 2000; 911: 240-253. (Pubitemid 30462086)
24. De Santi S, de Leon MJ, Rusinek H, Convit A, Tarshish CY, Roche A et al. Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging 2001; 22: 529-539. (Pubitemid 32607736)
25. Schroeter ML, Stein T, Maslowski N, Neumann J. Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients. Neuroimage 2009; 47: 1196-1206.
26. Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 2012; 367: 795-804.
27. de Calignon A, Polydoro M, Suá rez-Calvet M, William C, Adamowicz DH, Kopeikina KJ et al. Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 2012; 73: 685-697.
28. Narita K, Kosaka H, Okazawa H, Murata T, Wada Y. Relationship between plasma leptin level and brain structure in elderly: a voxel-based morphometric study. Biol Psychiatry 2009; 65: 992-994.
29. Miller JL, Couch J, Schwenk K, Long M, Towler S, Theriaque DW et al. Early childhood obesity is associated with compromised cerebellar development. Dev Neuropsychol 2009; 34: 272-283.
30. Stoodley CJ, Schmahmann JD. Evidence for topographic organization in the cerebellum of motor control versus cognitive and affective processing. Cortex 2010; 46: 831-844.
31. Bugg JM, Shah K, Villareal DT, Head D. Cognitive and neural correlates of aerobic fitness in obese older adults. Exp Aging Res 2012; 38: 131-145.